OSE Immunotherapeutics Announces Strategic Multi-Year Research Collaboration With Memorial Sloan-Kettering Cancer Center In New York Post author:Sam Post published:June 11, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion March 27, 2017 Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma August 13, 2017 Retrophin to Close Down Cambridge Operations, Cut Jobs in Consolidation Move March 8, 2017
Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion March 27, 2017